Endometrial carcinoma

被引:186
作者
Di Cristofano, Antonio
Ellenson, Lora Hedrick
机构
[1] Fox Chase Canc Ctr, Human Genet Program, Div Populat Sci, Philadelphia, PA 19111 USA
[2] Cornell Univ, Weill Med Coll, Dept Pathol, Div Gynecol Pathol, New York, NY 10021 USA
关键词
endometrioid; serous; molecular genetics; estrogen receptor; PTEN; mouse models; EPIDERMAL-GROWTH-FACTOR; ESTROGEN-RECEPTOR-ALPHA; PAPILLARY SEROUS CARCINOMA; CLEAR-CELL-CARCINOMA; FEMALE REPRODUCTIVE-TRACT; WNT SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; FACTOR-I; MICROSATELLITE INSTABILITY; MESSENGER-RNA;
D O I
10.1146/annurev.pathol.2.010506.091905
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Endometrial carcinoma, a common malignancy of the female genital tract, is composed of a number of tumor types with different light-microscopic features, molecular genetic alterations, and prognoses. In addition, hormonal influences significantly impact growth regulatory pathways and interact with genetic alterations in the pathogenesis of at least some types of endometrial carcinorna. These factors have complicated the analyses of endometrial carcinoma, but over the past decades, awareness of the different types of endometrial carcinoma, in addition to careful clinicopathological studies, molecular analyses, and animal studies of the biological underpinnings of the different tumor types, has increased. We present the current understanding of endometrial carcinoma, from a molecular vantage point, highlighting what are presently thought to be the fundamental pathways involved in the development and progression of the major types of endometrial carcinorna.
引用
收藏
页码:57 / 85
页数:29
相关论文
共 151 条
[61]  
KURMAN RJ, 1985, CANCER-AM CANCER SOC, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO
[62]  
2-X
[63]  
Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO
[64]  
2-L
[65]   Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression [J].
Lax, SF ;
Pizer, ES ;
Ronnett, BM ;
Kurman, RJ .
HUMAN PATHOLOGY, 1998, 29 (06) :551-558
[66]   THE PROTOONCOGENE C-FMS IS OVEREXPRESSED IN ENDOMETRIAL CANCER [J].
LEISEROWITZ, GS ;
HARRIS, SA ;
SUBRAMANIAM, M ;
KEENEY, GL ;
PODRATZ, KC ;
SPELSBERG, TC .
GYNECOLOGIC ONCOLOGY, 1993, 49 (02) :190-196
[67]   Integration of the extranuclear and nuclear actions of estrogen [J].
Levin, ER .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (08) :1951-1959
[68]  
Levine RL, 1998, CANCER RES, V58, P3254
[69]   PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J].
Li, J ;
Yen, C ;
Liaw, D ;
Podsypanina, K ;
Bose, S ;
Wang, SI ;
Puc, J ;
Miliaresis, C ;
Rodgers, L ;
McCombie, R ;
Bigner, SH ;
Giovanella, BC ;
Ittmann, M ;
Tycko, B ;
Hibshoosh, H ;
Wigler, MH ;
Parsons, R .
SCIENCE, 1997, 275 (5308) :1943-1947
[70]   The Wnt signaling pathway in development and disease [J].
Logan, CY ;
Nusse, R .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2004, 20 :781-810